We are live on ! Find out more
FG

Fairman Group Portfolio holdings

AUM $127M Turnover 8.16%
1-Year Est. Return 6.28%
This Fund
S&P 500
This Quarter Est. Return
-0.7%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$10.7M
Cap. Flow
+$12.2M
Cap. Flow %
10.02%
Top 10 Hldgs %
71.26%
Holding
408
New
4
Increased
57
Reduced
137
Closed
62
Avg Time Held
1 year
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
0.9 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.54%
2 Technology 33.65%
3 Financials 9.87%
4 Industrials 5.98%
5 Healthcare 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DEO icon
226
Diageo
DEO
$52.3B
$2.03K ﹤0.01%
16
– –
2023 Q4
4 quarters
IJK icon
227
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
$2K ﹤0.01%
22
– –
2023 Q4
4 quarters
MEDP icon
228
Medpace
MEDP
$17.5B
$1.99K ﹤0.01%
6
-7
-54% -$2.37K
2023 Q4
4 quarters
CCK icon
229
Crown Holdings
CCK
$12.4B
$1.99K ﹤0.01%
24
– –
2023 Q4
4 quarters
RTX icon
230
RTX Corp
RTX
$252B
$1.97K ﹤0.01%
17
– –
2023 Q4
4 quarters
FLJP icon
231
Franklin FTSE Japan ETF
FLJP
$4.19B
$1.92K ﹤0.01%
67
– –
2024 Q2
2 quarters
TXN icon
232
Texas Instruments
TXN
$255B
$1.88K ﹤0.01%
10
-10
-50% -$2K
2023 Q4
4 quarters
VMC icon
233
Vulcan Materials
VMC
$32.7B
$1.8K ﹤0.01%
7
-8
-53% -$2.15K
2023 Q4
4 quarters
TYL icon
234
Tyler Technologies
TYL
$14.9B
$1.73K ﹤0.01%
3
-3
-50% -$1.81K
2023 Q4
4 quarters
MDT icon
235
Medtronic
MDT
$122B
$1.61K ﹤0.01%
20
-16
-44% -$1.39K
2023 Q4
4 quarters
APTV icon
236
Aptiv
APTV
$9.38B
$1.57K ﹤0.01%
26
-26
-50% -$1.59K
2023 Q4
4 quarters
ADSK icon
237
Autodesk
ADSK
$51.2B
$1.48K ﹤0.01%
5
-5
-50% -$1.48K
2023 Q4
4 quarters
UL icon
238
Unilever
UL
$139B
$1.47K ﹤0.01%
23
– –
2023 Q4
4 quarters
PRME icon
239
Prime Medicine
PRME
$655M
$1.46K ﹤0.01%
500
– –
2023 Q4
4 quarters
APD icon
240
Air Products & Chemicals
APD
$66B
$1.45K ﹤0.01%
5
-6
-55% -$1.88K
2023 Q4
4 quarters
HQY icon
241
HealthEquity
HQY
$7.65B
$1.44K ﹤0.01%
15
-15
-50% -$1.4K
2023 Q4
4 quarters
NEE icon
242
NextEra Energy
NEE
$165B
$1.43K ﹤0.01%
20
-20
-50% -$1.55K
2023 Q4
4 quarters
PPG icon
243
PPG Industries
PPG
$24B
$1.43K ﹤0.01%
12
– –
2023 Q4
4 quarters
BRO icon
244
Brown & Brown
BRO
$22.7B
$1.43K ﹤0.01%
14
-15
-52% -$1.6K
2023 Q4
4 quarters
LYV icon
245
Live Nation Entertainment
LYV
$40.2B
$1.43K ﹤0.01%
11
-12
-52% -$1.51K
2023 Q4
4 quarters
NOVT icon
246
Novanta
NOVT
$5.1B
$1.38K ﹤0.01%
9
-9
-50% -$1.52K
2023 Q4
4 quarters
EBAY icon
247
eBay
EBAY
$54.7B
$1.36K ﹤0.01%
22
– –
2023 Q4
4 quarters
GE icon
248
GE Aerospace
GE
$324B
$1.34K ﹤0.01%
8
– –
2023 Q4
4 quarters
SSD icon
249
Simpson Manufacturing
SSD
$7.18B
$1.33K ﹤0.01%
8
-9
-53% -$1.65K
2023 Q4
4 quarters
VRTS icon
250
Virtus Investment Partners
VRTS
$814M
$1.32K ﹤0.01%
6
– –
2023 Q4
4 quarters

Similar funds

Fairman Group's Q4 2024 Portfolio in Review

As of Q4 2024, Fairman Group held 408 positions worth $121M, up 9.7% from $111M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Fairman Group deployed $12.2M of net new capital in Q4 2024, opening 4 new positions and adding to 57 existing holdings. Its largest new stake was Vertex: 6,129 shares worth $327K.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 42% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was W.R. Berkley, an estimated $1.02M trimmed.

  • Fairman Group's largest Q4 2024 buy was Vertex: 6,129 shares worth $327K.
  • Fairman Group added most to Accenture in Q4 2024, an estimated $7.97M increase.
  • Fairman Group's biggest Q4 2024 reduction was W.R. Berkley, cutting an estimated $1.02M.
  • Fairman Group fully exited Bloom Energy in Q4 2024, selling an estimated $104K.
  • Fairman Group's ten largest holdings make up 71% of its $121M portfolio in Q4 2024.
  • Fairman Group opened 4 new positions and closed 62 in Q4 2024.
  • Fairman Group's portfolio value rose 9.7% quarter-over-quarter to $121M.

Based on Fairman Group's 13F filing for Q4 2024, filed 29 Jan 2025.